Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Settings
ARNA [NASD]
Arena Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.26 Insider Own0.60% Shs Outstand242.03M Perf Week-6.61%
Market Cap992.32M Forward P/E- EPS next Y-0.50 Insider Trans-14.25% Shs Float240.67M Perf Month-8.69%
Income-59.50M PEG- EPS next Q-0.14 Inst Own58.50% Short Float12.47% Perf Quarter-7.66%
Sales42.40M P/S23.40 EPS this Y-211.10% Inst Trans20.90% Short Ratio7.85 Perf Half Y-1.91%
Book/sh0.55 P/B7.45 EPS next Y3.80% ROA-18.80% Target Price7.08 Perf Year-33.76%
Cash/sh1.00 P/C4.12 EPS next 5Y- ROE-67.10% 52W Range3.26 - 6.59 Perf YTD18.16%
Dividend- P/FCF- EPS past 5Y31.20% ROI-89.20% 52W High-37.78% Beta-0.73
Dividend %- Quick Ratio3.50 Sales past 5Y28.90% Gross Margin76.40% 52W Low25.77% ATR0.16
Employees325 Current Ratio3.60 Sales Q/Q80.90% Oper. Margin- RSI (14)40.12 Volatility3.33% 3.89%
OptionableYes Debt/Eq0.54 EPS Q/Q16.70% Profit Margin- Rel Volume0.47 Prev Close4.19
ShortableYes LT Debt/Eq0.52 EarningsMay 11 AMC Payout- Avg Volume3.82M Price4.10
Recom2.70 SMA20-3.52% SMA50-7.72% SMA200-4.94% Volume1,822,349 Change-2.15%
May-12-15Reiterated WallachBeth Buy $8 → $6
Jan-23-15Initiated RBC Capital Mkts Sector Perform $5
Aug-07-14Reiterated WallachBeth Buy $9 → $8
Nov-15-13Initiated WallachBeth Buy $9
Oct-03-13Initiated Cowen Market Perform $4.50
Oct-25-10Reiterated Barclays Capital Underweight $3 → $2
Sep-20-10Reiterated UBS Neutral $7 → $2
Sep-17-10Downgrade Davenport Buy → Neutral
Sep-14-10Downgrade Barclays Capital Equal Weight → Underweight $4 → $3
Aug-23-10Reiterated UBS Neutral $3.50 → $7
Jul-16-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $1
Jul-02-10Reiterated UBS Buy $40 → $38
Feb-04-10Upgrade Rodman & Renshaw Mkt Underperform → Mkt Perform
Dec-17-09Initiated Jefferies & Co Hold $4
Sep-21-09Downgrade Leerink Swann Outperform → Mkt Perform $6
Sep-18-09Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $3
Sep-15-09Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Aug-18-09Initiated JMP Securities Mkt Perform
Jun-24-09Initiated Rodman & Renshaw Mkt Outperform $9
Mar-16-09Downgrade Canaccord Adams Hold → Sell
May-26-15 08:00AM  Arena Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference PR Newswire
May-19-15 01:04PM  ARENA PHARMACEUTICALS INC Financials
May-14-15 08:00AM  Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at Upcoming Medical Meetings PR Newswire
12:22AM  5 Key Takeaways Following Arena's Q1 Results at Investopedia
May-13-15 08:11PM  10-Q for Arena Pharmaceuticals, Inc. at Company Spotlight
11:35AM  5 New Biotech Developments Worth Watching
May-12-15 09:10AM  Arena Pharmaceuticals 1Q Loss Narrower-Than-Expected - Analyst Blog
May-11-15 07:48PM  Arena Pharmaceuticals reports 1Q loss
05:00PM  Arena Pharmaceuticals Inc Earnings call Call scheduled for 5:00 pm ET today
04:22PM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
04:07PM  Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2015 Financial Results PR Newswire
04:01PM  Arena Pharmaceuticals and Roivant Sciences Enter into Collaboration for Nelotanserin, a Novel Inverse Agonist of the 5-HT2A Receptor PR Newswire
07:07AM  Q1 2015 Arena Pharmaceuticals Inc Earnings Release - After Market Close
May-08-15 08:00AM  Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference PR Newswire
May-07-15 04:00PM  Will Arena Pharmaceuticals (ARNA) Surprise this Earnings? - Analyst Blog
03:03PM  3 Things Arena's Management Wants You to Know at Investopedia
08:27AM  Arena Pharmaceuticals to Host First Quarter 2015 Financial Results Conference Call and Webcast on Monday, May 11 at noodls
08:00AM  Arena Pharmaceuticals to Host First Quarter 2015 Financial Results Conference Call and Webcast on Monday, May 11 PR Newswire
May-06-15 07:07AM  Q1 2015 Arena Pharmaceuticals Inc Earnings Release - After Market Close
May-05-15 05:13PM  The Westaim Corporation Announces $200 Million Bought Deal Private Placement and Concurrent Private Placement of Special Warrants to Pursue New Business Lines at noodls
Apr-30-15 01:11PM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Apr-29-15 08:31AM  Arena Pharmaceuticals Reports Favorable Results from Phase 1 Single-Ascending Dose Clinical Trial of APD371 at noodls
08:00AM  Arena Pharmaceuticals Reports Favorable Results from Phase 1 Single-Ascending Dose Clinical Trial of APD371 PR Newswire
Apr-28-15 01:33PM  5 Biotech Stocks to Avoid After Monday's Slump - Analyst Blog
09:05AM  Arena Adds Most New Customers in Company History to Close Record Quarter CNW Group
Apr-27-15 06:58PM  Arena Solutions and Q Point Technology Partner to Offer Arena PLM with Q Point's Online Green Data Exchange CNW Group -6.01%
Apr-23-15 06:37PM  Orexigen's Obesity Drug Contrave Faces Generic Threat - Analyst Blog
08:09AM  Eisai and Arena Pharmaceuticals Complete Registrational Trials of an Extended Release Formulation of Lorcaserin at noodls
Apr-21-15 09:30AM  Zacks Rank #5 Additions for Tuesday - Tale of the Tape
Apr-13-15 05:09PM  Arena, Eisai Finish Phase I Studies on Obesity Drug Belviq - Analyst Blog
Apr-10-15 08:31AM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events
08:00AM  Eisai and Arena Pharmaceuticals Complete Registrational Trials of an Extended Release Formulation of Lorcaserin PR Newswire
02:00AM  Eisai Drops On US Job Cuts, Still A Stunning Run On Alzheimer's Drug With Biogen at Barrons.com
Apr-09-15 08:12AM  Arena Pharmaceuticals to Present at the Annual Needham Healthcare Conference at noodls
08:00AM  Arena Pharmaceuticals to Present at the Annual Needham Healthcare Conference PR Newswire
Apr-08-15 10:00AM  Arena Pharmaceuticals Up on Belviq's New Patent Approval - Analyst Blog
08:14AM  Calls look to ride Arena Pharma
Apr-07-15 11:34AM  Arena Pharmaceuticals (ARNA) Stock Gains Today on New Patent Approval at TheStreet
10:52AM  Arena Pharmaceuticals shares rise on weight loss drug patent
08:17AM  Arena Pharmaceuticals Receives Additional Patent for BELVIQ® (lorcaserin HCl) from United States Patent and Trademark Office at noodls
08:00AM  Arena Pharmaceuticals Receives Additional Patent for BELVIQ® (lorcaserin HCl) from United States Patent and Trademark Office PR Newswire
Apr-02-15 08:26PM  3 Ways Arena Can Boost Shareholder Value at Investopedia
02:40PM  Vivus Goes on a Diet: Sales Reps are Cut, but Will FDA Help Save Money? at The Wall Street Journal
01:47PM  Sports & Entertainment Group Announces Strategic Partnership with AEG Facilities for Québec City Arena at noodls
Mar-27-15 08:25AM  Ahead of the Bell: Orexigen shares rise
Mar-19-15 09:30AM  Zacks Rank #5 Additions for Thursday - Tale of the Tape
Mar-16-15 06:23AM  Tondiraba Ice Arena wins Concrete Building of the Year title at noodls
Mar-11-15 09:30AM  Zacks Rank #5 Additions for Wednesday - Tale of the Tape
Mar-09-15 05:06PM  Novo Nordisk's Saxenda: New Data from Phase IIIa Study - Analyst Blog
Mar-07-15 12:40AM  Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2014 Financial Results at noodls
Mar-05-15 11:20PM  Is Arena Pharmaceuticals In Trouble? at Investopedia
Mar-04-15 07:09PM  10-K for Arena Pharmaceuticals, Inc. at Company Spotlight +6.93%
11:35AM  Biotech Stock Roundup: Orexigen Soars on Contrave Data, Amgen Scores in Study - Analyst Blog
09:34AM  Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast on Monday, March 2 at noodls
Mar-03-15 04:26PM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure -5.61%
01:54PM  Orexigen Soars On Obesity Drug's Surprise Health Boon at Investor's Business Daily
11:51AM  Orexigen Weight-Loss Pill Shows Surprise Heart-Safety Benefit at TheStreet
10:28AM  Arena Pharmaceuticals' Q4 Loss Wider than Expected - Analyst Blog Zacks
Mar-02-15 06:45PM  Arena Pharmaceuticals Misses Q4 Expectations Benzinga -5.10%
05:14PM  Arena Pharmaceuticals reports 4Q loss AP
04:01PM  Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2014 Financial Results PR Newswire
Feb-27-15 04:22PM  Will Arena Pharmaceuticals (ARNA) Disappoint on Q4 Earnings? - Analyst Blog Zacks -5.05%
Feb-23-15 08:00AM  Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast on Monday, March 2 PR Newswire
Feb-20-15 03:47PM  Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus at TheStreet -5.10%
Feb-18-15 08:00AM  Arena Pharmaceuticals to Present at the 2015 RBC Capital Markets Healthcare Conference PR Newswire
06:38AM  A Vue cinema will become the UK's first eSports arena next month at Engadget
Feb-17-15 09:06AM  Arena's Broader Product Footprint Drives Q4 Growth Of 38 Percent CNW Group
Feb-03-15 10:00AM  Eforb: From Indie Game Development to Monetization and Distribution Platform CNW Group
08:46AM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online
05:00AM  Arena Pharmaceuticals Announces Marketing Approval in South Korea of BELVIQ® (lorcaserin HCl) for Weight Management PR Newswire
Feb-02-15 08:00AM  Arena Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference PR Newswire
Jan-29-15 08:54AM  An Early Version Of Samsung's Next Galaxy Phone Might Have Just Leaked Business Insider
Jan-23-15 04:52PM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
11:49AM  Brazil's $3 Billion World Cup Stadiums Are Turning Into White Elephants 6 Months Later Business Insider
06:18AM  Coverage initiated on Arena Pharm by RBC Capital Mkts Briefing.com
06:00AM  Biotech Stock Mailbag: Arena Pharma, Agenus, EnteroMedics at TheStreet
Jan-22-15 04:00PM  Arena Pharmaceuticals to Raise Fund Via Share Issuance - Analyst Blog Zacks
Jan-21-15 05:45PM  Stock Pops & Drops: CHL, ARNA, MBLY & ANTM CNBC -10.96%
03:10PM  Mid-Afternoon Market Update: Alnylam Pharmaceuticals Drops Following Equity Offering; Insperity Shares Spike Higher Benzinga
10:42AM  Mid-Morning Market Update: Markets Mixed; UnitedHealth Profit Tops Expectations Benzinga
08:45AM  Arena Pharmaceuticals Announces Agreement to Sell Common Stock Benzinga
08:45AM  Arena Pharmaceuticals Announces Agreement to Sell Common Stock PR Newswire
Jan-20-15 05:16PM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events EDGAR Online
04:04PM  Arena Pharmaceuticals Announces Public Offering of Common Stock PR Newswire
12:34PM  Did you know Arena Pharmaceuticals is a CAR-T company? Neither did I. Next week, it will be gene therapy. I guess anything is better than being known for peddling a mediocre weight loss pill with disappointing fourth-quarter sales . Yahoo Finance Contributors
Jan-16-15 02:20PM  Arena Pharmaceuticals Doses for Cardiovascular Study - Analyst Blog Zacks
Jan-15-15 09:57AM  Can the Uptrend Continue for Arena Pharma (ARNA)? - Tale of the Tape Zacks -8.29%
Jan-14-15 01:55PM  5 Obesity Stocks Investors Are Watching Benzinga -6.28%
09:00AM  Indie Game Developer Eforb Launches Game Publishing Service: Gamebox Arena CNW Group
Jan-12-15 04:21PM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online
08:00AM  Arena Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Ralinepag for Pulmonary Arterial Hypertension PR Newswire
Jan-09-15 08:00AM  Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV PR Newswire -5.73%
07:32AM  ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online
Jan-07-15 01:00PM  Midday movers: Alkermes, Lennar, Radian Group & more at CNBC +76.20%
12:30PM  Arena Pharma surges on data from autoimmune drug study AP
08:00AM  Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune Diseases PR Newswire
Jan-06-15 08:00AM  Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference PR Newswire -5.68%
Dec-23-14 04:49PM  FDA clears Novo Nordisk's weight loss drug Saxenda AP -5.79%
Dec-19-14 02:09PM  Orexigen Therapeutics Gains On Diet Pill Nod From European Committee Benzinga
Dec-12-14 11:58AM  Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals Yahoo Finance Blogs
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. It is also developing a portfolio of programs in various therapeutic areas, including cardiovascular, central nervous system, and metabolic diseases. Its products under development include Ralinepag, an agonist of the prostacyclin receptor intended for the treatment of vascular diseases, including potentially pulmonary arterial hypertension that is in Phase II clinical trials. The company's products under development also comprise APD334, an modulator of the sphingosine 1-phosphate subtype 1 receptor for the treatment of a various autoimmune diseases, which has completed Phase I single-ascending dose trials; APD371, an agonist of the cannabinoid receptor 2 that is in Phase I clinical trials intended for the treatment of pain and fibrotic diseases; and Temanogrel, an inverse agonist of the serotonin 2A receptor intended for the treatment of thrombotic diseases, which has completed single- and multiple-ascending dose Phase I clinical trials. In addition it manufactures drug products under a toll manufacturing agreement for Siegfried AG. The company was founded in 1997 and is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WOODS RANDALL EDirectorMar 30Option Exercise1.3976,268105,719121,380Apr 01 06:58 PM
WOODS RANDALL EDirectorMar 30Sale4.4976,268342,25345,112Apr 01 06:58 PM
SPECTOR STEVEN WEVP, General Counsel & SecMar 17Option Exercise1.5170,000105,803198,039Mar 18 05:45 PM
SPECTOR STEVEN WEVP, General Counsel & SecMar 17Sale5.0070,000350,000128,039Mar 18 05:45 PM
LIEF JACKPresident and CEOMar 03Option Exercise1.49125,000186,250622,189Mar 04 05:54 PM
SPECTOR STEVEN WEVP, General Counsel & SecJan 08Option Exercise6.1645,000277,200173,039Jan 08 09:08 PM
SPECTOR STEVEN WEVP, General Counsel & SecJan 08Sale6.2645,000281,700128,039Jan 08 09:08 PM
SHANAHAN WILLIAM R JRSVP & Chief Medical OfficerJan 07Option Exercise1.4950,00074,500100,000Jan 08 09:07 PM
SHANAHAN WILLIAM R JRSVP & Chief Medical OfficerJan 07Sale5.4950,000274,50050,000Jan 08 09:07 PM
LIEF JACKChairman, President and CEOSep 17Option Exercise1.49100,000149,000441,039Sep 19 04:50 PM
LIEF JACKChairman, President and CEOJul 01Sale5.85223,5251,308,582361,039Jul 03 04:38 PM
BELCHER DONALD DDirectorJun 27Option Exercise5.462,47313,50396,585Jun 27 06:49 PM
BELCHER DONALD DDirectorJun 27Sale5.852,47314,46794,112Jun 27 06:49 PM